The post SHIB Burn Rate Surges 53,000% But Price Fails to Follow appeared on BitcoinEthereumNews.com. Shiba Inu’s burn rate recorded a dramatic spike in the lastThe post SHIB Burn Rate Surges 53,000% But Price Fails to Follow appeared on BitcoinEthereumNews.com. Shiba Inu’s burn rate recorded a dramatic spike in the last

SHIB Burn Rate Surges 53,000% But Price Fails to Follow

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Shiba Inu’s burn rate recorded a dramatic spike in the last 24 hours, with over 172 million SHIB tokens permanently removed from circulation, a 53,000% increase over the prior period. Despite the headline-grabbing figure, the token’s price has not responded in kind.

SHIB is trading around $0.00000540, down approximately 2.73% in the last 24 hours. The broader crypto market, weighed down by Bitcoin’s retreat, has pulled altcoins lower across the board. SHIB has not been spared.

The Burn Math: Why 172 Million Tokens Barely Moves the Needle

The 172 million tokens removed sounds significant in isolation. In context, it is not. SHIB has a circulating supply exceeding 585 trillion tokens. The recent burn reduced that supply by approximately 0.00003%.

That figure is not a rounding error, it is the core challenge facing SHIB’s deflationary model. For burns to exert meaningful upward pressure on price, the rate of destruction would need to be sustained at far higher volumes, over an extended period, or be paired with strong ecosystem demand through Shibarium, the project’s Layer-2 blockchain.

Single-day burn events, even dramatic ones, do not change the supply-demand equation in any measurable way at this scale. Investors watching burn metrics as price catalysts should treat isolated spikes with caution.

Chart Signals Flash Warning as Key Support Comes Under Pressure

The technical picture adds another layer of concern. SHIB has slipped beneath its short and mid-term moving averages, a pattern that typically indicates sellers have the upper hand. Price is currently testing support at $0.00000545.

That level carries weight. A hold there opens the door to a short-term bounce toward $0.00000560, particularly as momentum indicators approach oversold territory. Oversold readings do not guarantee a reversal, but they can attract short-term buyers looking for a technical rebound.

If that support fails, attention shifts to $0.00000530. A confirmed break below that level would establish another lower low on the chart, a bearish structural signal that could invite further selling. Trading volume recently hit approximately $179 million, a figure that reflects active participation but skews toward distribution rather than accumulation, given current price direction.

Source: https://coinpaper.com/15233/shib-burn-rate-jumps-53-000-but-price-drops-over-2-here-s-why-it-doesn-t-matter

Market Opportunity
SHIBAINU Logo
SHIBAINU Price(SHIB)
$0.000005394
$0.000005394$0.000005394
+1.01%
USD
SHIBAINU (SHIB) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Vitalik Buterin to Ethereum Developers: Build It Like It Has to Last Without You

Key Takeaways Vitalik Buterin wants Ethereum apps built to survive without developers, corporate servers, or trusted third parties Two major […] The post Vitalik
Share
Coindoo2026/03/07 15:49
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

Short-term profit-taking pushes Bitcoin back below key $70K level – What next?

The post Short-term profit-taking pushes Bitcoin back below key $70K level – What next? appeared on BitcoinEthereumNews.com. Bitcoin [BTC] rallied as high as $74
Share
BitcoinEthereumNews2026/03/07 16:09